MARKET

BDX

BDX

BECTON DICKINSN
NYSE

Real-time Quotes | Nasdaq Last Sale

246.45
+5.57
+2.31%
After Hours: 246.45 0 0.00% 18:59 03/05 EST
OPEN
241.84
PREV CLOSE
240.88
HIGH
247.61
LOW
240.95
VOLUME
1.11M
TURNOVER
--
52 WEEK HIGH
284.97
52 WEEK LOW
197.75
MARKET CAP
71.61B
P/E (TTM)
47.37
1D
5D
1M
3M
1Y
5Y
Becton Dickinson (BDX) Down 3.3% Since Last Earnings Report: Can It Rebound?
Zacks.com · 1d ago
How to Improve The Timing of Investment Decisions in Becton Dickinson $BDX
Mar 05, 2021 (Stock Traders Daily via COMTEX) -- Some people say that timing does not matter, but it does. If you were to buy Becton Dickinson (NYSE: BDX) at...
Stock Traders Daily · 1d ago
Becton Dickinson & Co. stock outperforms competitors despite losses on the day
Shares of Becton Dickinson & Co. slid 0.32% to $240.88 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P...
marketwatch.com · 2d ago
Pharmaceutical Packaging Market Worth USD 153.93 Billion by 2027; Know the COVID-19 Impact Analysis on Pharmaceutical Packaging Industry Worldwide | Fortune Business Insights(TM)
The global pharmaceutical packaging industry is expected to reach USD 153.93 billion by 2027, exhibit a CAGR of 6.4% during the forecast period. The growing adoption of novel and generic drugs in developing countries will have an excellent impact o...
GlobeNewswire · 3d ago
4 Medtech Leaders Have Upcoming Catalysts That Could Be Huge
247WallSt.com · 3d ago
DJ Becton Dickinson Buys Medication-Storage Company GSL Solutions
Dow Jones · 3d ago
BRIEF-BD Acquires GSL Solutions
reuters.com · 3d ago
Becton Dickinson: Terms of the Transaction Were Not Disclosed >BDX
Becton Dickinson: Terms of the Transaction Were Not Disclosed >BDX
Dow Jones · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BDX. Analyze the recent business situations of BECTON DICKINSN through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BDX stock price target is 281.57 with a high estimate of 300.00 and a low estimate of 260.00.
EPS
Institutional Holdings
Institutions: 2.07K
Institutional Holdings: 263.35M
% Owned: 90.64%
Shares Outstanding: 290.56M
TypeInstitutionsShares
Increased
566
15.27M
New
281
1.52M
Decreased
517
17.57M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+2.73%
Healthcare Equipment & Supplies
+2.13%
Key Executives
Chairman/Executive Director
Vincent Forlenza
President/Chief Executive Officer/Chief Operating Officer/Director
Thomas Polen
Chief Financial Officer/Executive Vice President/Chief Administrative Officer
Christopher Reidy
Corporate Executive
David Hickey
Executive Vice President/Chief Technology Officer
John DeFord
Chief Human Resource Officer/Executive Vice President/Director of Human Resources
Betty Larson
Corporate Executive
William Tozzi
Executive Vice President/Chief Technology Officer
John Deford
Executive Vice President
Simon Campion
Executive Vice President
Alexandre Conroy
Executive Vice President
Roland Goette
Executive Vice President
Samrat Khichi
Executive Vice President
James Lim
Executive Vice President
Alberto Mas
Chief Accounting Officer/Vice President/Controller
Thomas Spoerel
Lead Director/Independent Director
Marshall Larsen
Independent Director
Catherine Burzik
Independent Director
Christopher Ian Jones
Independent Director
R. Andrew Eckert
Independent Director
Claire Fraser
Independent Director
Jeffrey Henderson
Independent Director
Christopher Jones
Independent Director
David Melcher
Independent Director
Claire Pomeroy
Independent Director
Rebecca Rimel
Independent Director
Timothy Ring
Independent Director
Bertram Scott
Declaration Date
Dividend Per Share
Ex-Div Date
01/25/2021
Dividend USD 0.83
03/09/2021
11/24/2020
Dividend USD 0.83
12/09/2020
07/27/2020
Dividend USD 0.79
09/08/2020
04/28/2020
Dividend USD 0.79
06/08/2020
01/27/2020
Dividend USD 0.79
03/09/2020
11/25/2019
Dividend USD 0.79
12/09/2019
07/22/2019
Dividend USD 0.77
09/06/2019
04/29/2019
Dividend USD 0.77
06/06/2019
01/21/2019
Dividend USD 0.77
03/07/2019
11/19/2018
Dividend USD 0.77
12/07/2018
07/24/2018
Dividend USD 0.75
09/06/2018
04/23/2018
Dividend USD 0.75
06/07/2018
01/23/2018
Dividend USD 0.75
03/08/2018
11/21/2017
Dividend USD 0.75
12/07/2017
07/27/2017
Dividend USD 0.73
09/07/2017
05/24/2017
Dividend USD 0.73
06/07/2017
01/24/2017
Dividend USD 0.73
03/08/2017
11/22/2016
Dividend USD 0.73
12/07/2016
07/27/2016
Dividend USD 0.66
09/07/2016
05/25/2016
Dividend USD 0.66
06/07/2016
01/26/2016
Dividend USD 0.66
03/08/2016
11/24/2015
Dividend USD 0.66
12/08/2015
07/29/2015
Dividend USD 0.6
09/04/2015
05/20/2015
Dividend USD 0.6
06/05/2015
01/27/2015
Dividend USD 0.6
03/06/2015
12/08/2014
Dividend USD 0.6
12/08/2014
07/22/2014
Dividend USD 0.545
09/05/2014
05/20/2014
Dividend USD 0.545
06/05/2014
01/28/2014
Dividend USD 0.545
03/06/2014
11/26/2013
Dividend USD 0.545
12/06/2013
07/23/2013
Dividend USD 0.495
09/05/2013
About BDX
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Webull offers kinds of Becton Dickinson and Co stock information, including NYSE:BDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BDX stock methods without spending real money on the virtual paper trading platform.